4 studies found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Lung Diseases"
Show Display Options
Rank Status Study
1 Unknown  Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF
Conditions: Heart Failure, Congestive;   Dyspnea;   Pulmonary Edema
Intervention: Drug: Nesiritide
2 Recruiting TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
Condition: Pulmonary Tuberculosis
Interventions: Drug: rifampin;   Drug: rifapentine
3 Recruiting Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Biological: cixutumumab;   Drug: paclitaxel;   Drug: carboplatin;   Biological: bevacizumab
4 Recruiting Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage IB Cervical Cancer;   Stage II Endometrial Carcinoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage IVA Cervical Cancer
Interventions: Drug: ferumoxtran-10;   Procedure: diagnostic lymphadenectomy;   Procedure: axillary lymph node biopsy;   Procedure: 3-Tesla magnetic resonance imaging;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18

Indicates status has not been verified in more than two years